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Unstimulated Peripheral Blood Mononuclear Cells from 
Patients with the Hyper-lgD Syndrome Produce Cytokines 
Capable of Potent Induction of C-Reactive Protein and Serum 
Amyloid A in Hep3B Cells
Joost P. H. Drenth,1** Jos W. M. Van Der M eer,2+ and Irving Kushner*
The hyper-lgD and periodic fever syndrome (HIDS) and familial Mediterranean fever (FMF) are both characterized by attacks of 
periodic fever accompanied by acute phase responses that are substantially higher in HIDS than in FMF. To determine whether this 
difference could be due to differences in production of acute phase protein-inducing mediators, w e studied PBMC from HIDS and FMF 
patients in the inactive phase of disease. Unstimulated PBMC from patients with inactive HIDS released significantly more IL-1ß, IL-6, 
and TNF-a than did PBMC from patients with FMF, but unstimulated PBMC from the latter group released significantly more IL-1 ß 
and IL-6 compared with controls. Conditioned medium (CM) derived from PBMC of patients with inactive HIDS induced significantly 
greater CRP production and significantly higher mRNAs for CRP and SAA in Hep3B cells than did CM derived from the PBMC of 
patients with inactive FMF. Stimulation of PBMC with LPS led to further increases in cytokine production and in acute phase 
protein-inducing ability in both patient groups and in controls. These findings suggest that the greater acute phase response seen in 
HIDS compared with FMF reflects greater production of acute phase protein-inducing cytokines in the former patients and indicates 
that PBMC from inactive HIDS patients are already activated in vivo. Finally, the finding of both quantitative and qualitative differ­
ences in cytokine production by unstimulated PBMC from HIDS and FMF patients supports the likelihood of different pathogeneses 
of these diseases. The Journal of Immunology, 1996, 157: 4 0 0 -4 0 4 .
T he hyper-lgD and periodic fever syndrome (HIDS)3 is a rare 
disease characterized by recurrent febrile attacks with ab­
dominal complaints, lymphadenopathy, skin lesions, and 
joint involvement. Up to now, some 65 patients, mainly of European 
origin, have been recognized (1). A clinically similar entity, familial 
Mediterranean fever (FMF), is an autosomal recessive inflammatory 
disorder characterized by short episodes of fever, peritonitis, pleuritis, 
and arthritis (2), which predominantly affects non-Ashkenazi Jews, 
Armenians, and Arabs. The pathogenesis of these periodic fever syn­
dromes is unknown, but it is probable that attacks arise from dysregu- 
lation of the inflammatory response in both. For example, a lack of 
C5a inhibitor has been incriminated as a cause of the recurrent attacks 
of serositis in FMF (3).
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Inflammatory states are often accompanied by increased plasma 
concentrations of a group of acute phase proteins, including C-re­
active protein (CRP), serum amyloid A (SAA), fibrinogen, and
a ,-ac id  glycoprotein (AGP) (4). A number of inflammation-asso­
ciated cytokines, particularly IL-1, IL-6, and T N F -a  are consid­
ered the main inducers of their synthesis (5). Febrile attacks in both 
HIDS and FMF are accompanied by an acute phase response, 
which, however, differs in intensity. In HIDS, substantially higher 
serum concentrations of acute phase proteins are achieved during 
attacks than are seen in FM F (6 -8 ) .  This variation in acute phase 
response between the two syndromes could theoretically be due to 
a different quality of a hypothetical inflammatory stimulus, to dif­
ferences in production of inflammatory mediators influencing 
plasma protein synthesis, or to different responses of hepatocytes.
PBMC produce a wide range of cytokines capable of acute phase 
protein induction after exposure to bacterial LPS (9), and conditioned 
medium (CM) from such LPS-stimulated PBMC has been shown to 
induce acute phase reactants in human hepatoma cell lines (10, 11). 
Accordingly, we explored possible differences between these two pe­
riodic fever syndromes in production of acute phase protein-inducing 
mediators by comparing the abilities of PBMC from HIDS and FMF 
patients to produce three inflammation-associated cytokines. In addi­
tion, we compared the abilities of their CM both to induce production 
of the protein CRP and to induce expression of the mRNAs for the 
two major human acute phase protein genes, CRP and SAA, in the 
human hepatoma cell line Hep3B.
Materials and Methods
Patients
Eight patients with HIDS (four male, mean age; 25.9 yr); six patients with 
FMF (three male, mean age: 25.3 yr), and seven healthy Dutch volunteers 
(seven males, mean age: 30.3 yr) took part in the study. The diagnoses of 
HIDS and FMF were made according to standard criteria listed elsewhere
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( 1. 2). The patients with HIDS were all of Dutch origin, while five patients 
with FMF came from Turkey and one from Greece. The patients refrained 
from taking any medication during the study, and all patients were asymp­
tomatic at the time of blood drawing. The FMF patients had normal renal 
function and were, apart from the study period, receiving continuous treat­
ment with colchicine (1-1.5 mg/day).
Isolation o f  PBMC a n d  preparation  o f  CM
peripheral blood was drawn into sterile 10-ml tubes containing 0.2 mg 
Ei >TA. PBMC were isolated by buoyant density gradient centrifugation on 
Percoli (12). The cells from the interphase were aspirated and washed twice 
in sterile saline. After the last washing, cells were resuspended at a con­
es itration of 5 X 106/ml in RPMI 1640 medium (Dutch modification; Flow 
L ibs, Irvine, Scotland) supplemented with 2 mM L-glutamine, 1 mM pyru- 
\ e, and 500 /ig/ml gentamicin. Medium was loaded onto a 50-ml syringe 
and forced through a 0.2-/xm filter by manual force to remove endotoxin 
and other cytokine-inducing material (13). Heat-inactivated (30 min at 
5ft C) pooled human sera (5%) was added after filtration. PBMC were 
re uspended at a concentration of 5 X 106/ml in round-bottom 96-well 
plastic tissue culture plates and incubated either with or without 100 ng/ml 
E.u hericliia coli LPS at 37°C in a humidified atmosphere containing 5% 
C( f° r 24 h. Fifty microliters of the PBMC suspension was applied to 
cytospin centrifugation, and the contribution of monocytes to the PBMC 
solution w'as assessed microscopically under high powered view. The con- 
triluition of monocytes to the PBMC solution was similar for each group 
(HIDS, 17.5 ±  5.8%; FMF, 16 ±  6%; controls, 18 ±  8.6%) After incu­
bai ion, the culture plates were centrifuged at 4000 X g for 10 min to 
remove cellular material. Cell supematants (CM) were then aspirated and 
si red at -7 0 °C .  A baseline value for CRP was determined for the CM of 
th patients and controls. This baseline value was subtracted from the total 
an mnt of CRP subsequently released into the medium by Hep3B cells to 
calculate actual CRP production.
Cultures o f Hep3B cells
H' man hepatoma cells, Hep3B. were maintained in RPMI 1640 medium 
su1 plemented with 10% fetal bovine serum. Cells were subcultured weekly 
aft r trypsinization. Induction of acute phase proteins was conducted when 
ce s were confluent, usually on day 6 after subculture. Hep3B cells were 
ini ibated at 37°C in 35-mm dishes containing a total of I ml RPMI 1640 
sin ilemented with 1 /xM dexamethasone and 10% CM. The medium was 
collected after 24 h and stored at - 7 0 ° C  until assay.
EL ISAs
CR11 and SAA concentrations were measured in duplicate in sera obtained 
fr< i patients and healthy controls at the time of isolation of the PBMC and 
in îedia from Hep3B cells by ELISAs as previously reported (14, 15). 
Immulon III Dividastrip wells were coated overnight at 4°C with 1:1000 
dilution of goat anti-human CRP, IgG fraction (Atlantic Antibodies no. 
89134) in 100 /xl Tris-buffered saline (TBS). After three washes with 200 
Ml I BS containing 0.05% Tween-20, 200 /x1 of 1% BSA in TBS was added 
to each well to block nonspecific binding. Samples were diluted in glass 
tubes in RPMI 1640 with 1% BSA. Wells were washed before 100-/xl 
aliquots of samples and standards were added and incubated at 37°C for 
- h. After three washes, 100 /xl of PBS containing 1 ng/ml biotinylated, 
sheep anti-human CRP (Cappel Laboratories, West Chester, PA; no. 
55122) was added. This Ab was biotinylated using Pierce (Rockford, IL) 
Immunopure NHS-LC Biotin according to the manufacturer’s protocol. 
After incubation for 1 h at 37°C and washing with TBS-Tween, 100 ¿¿1 of 
^rqnavidin-horseradish peroxidase conjugate (diluted 1:1000 in PBS) was 
added and incubated for 1 h at 37°C. Wells were washed before the 
sub trate was added (OPD kit; Sigma Chemical Co., St. Louis, MO). 
The reaction was stopped by 2 M H2S 0 4 and absorbance was measured 
at 490 nm.
T NF-a and IL-1/3 were assayed by ELISAs developed in our laboratory 
in Cleveland, OH. Immulon III plates were coated for 2 h at 37° with 100
Ml ;u ti-TN F-a mAb (Boehringer Mannheim, Indianapolis, IN) diluted 1:40
t
>n a bicarbonate buffer, pH 9.0, and placed overnight at 4°C. After five 
washes with TBS containing 0.05% Tween-20, nonspecific binding of pro­
teins to the plastic was blocked by 3 h of incubation with 200 /xl nonfat dry 
roilk in bicarbonate buffer. After five washes, 100-pd samples and stan­
dards were allowed to incubate for 2 h at 37°C. Each sample was assayed 
ln duplicate. After five washes, polyclonal rabbit anti-human T N F-a  (En­
dogen, Boston, MA), diluted 1:1000 in PBS containing 2% nonfat dry milk 
was incubated for 2 h at 37°C. After incubation with horseradish-conju- 
"aied goat anti-rabbit antiserum (Tago Immunochemicals, Burlingame, 
CA) diluted 1:1000 in PBS with 2% nonfat dry milk, OPD substrate (Sig- 
n,a) was used. After a few minutes, the color development was stopped
with 50 /llI 2N sulfuric acid and absorbance measured at 490 nm. The lower 
limit of detection was 15 pg/ml.
The ELISA for IL-1 ß  involved coating Immulon III plates for 24 h at 
4°C with polyclonal anti-IL-1/3 Ab diluted 1:9000 in PBS. The IL - lß  poly­
clonal Ab was purchased from Cistron Biotechnology (Pine Brook, NJ) and 
does not react with pro-IL-lß. The plates were washed three times with 
PBS containing 0.05% Tween-20 and were incubated for 90 min at room 
temperature with PBS containing 5% nonfat dry milk. After three washes, 
IOO-/L1I samples and standards were added and incubated for 90 min at 
room temperature. After washing again, polyclonal rabbit anti-human 
IL - lß  antiserum diluted 1:4000 in PBS containing 1% nonfat dry milk was 
added, and after 90 min at room temperature, horseradish peroxidase-con- 
jugated goat anti-rabbit antiserum (Tago) diluted 1:3000 was added and the 
plate was incubated for an additional hour. After washing, OPD solution 
(Sigma) was added, and the color development terminated after approxi­
mately 5 min with 50 jxl 2N sulfuric acid. Optical density was read at 490 
nm. The lower limit of detection with this assay is 7 pg/ml.
IL-6 was measured using a commercial sandwich ELISA (R&D Sys­
tems, Inc., Minneapolis, MN). The assays were conducted according to the 
manufacturer’s instructions and all samples were tested in duplicate.
RNA isolation and analysis
Total RNA was isolated from stimulated Hep3B cells by guanidinium iso- 
thiocyanate lysis following a modification of the method of Chomczynski 
and Sacchi (16). RNA samples (15 /xg per lane) were heat denaturated at 
65°C in a solution consisting of 50% deionized formamide, 2 M formal­
dehyde in 0.2 M 3-(/V-morpholino)propane sulfonic acid buffer, pH 7.0, 
with 10 mM EDTA, and then fractionated on 1% agarose gels containing 
2.2 M formaldehyde. After transfer to MagnaGraph nylon (Micron Sepa­
rations Inc., Westboro, MA) by 3 h of vacuum blotting, RNA was UV 
cross-linked to the membrane. Dried membranes were photographed under 
UV translumination. Prehybridization (4 h) and hybridization (18 h) with 
CRP and SAA cDNA probes labeled with [32P]dCTP by the random primer 
method (10ri cpm) were performed at 42°C in hybridization buffer contain­
ing 50% deionized formamide, 5X standard saline solution (SSC), IX 
Denhardt’s solution, 1% SDS, and 10 mg/ml denaturated salmon sperm 
DNA. Following hybridization, nonspecifically bound radioactivity was 
removed from membranes by washing twice with 6X SSC, 0.1% SDS at 
room temperature for 30 min, followed by two subsequent washes for 15 
min with 0.1X SSC, 0.1% SDS at 62°C. The membranes were then ex­
posed at —70°C to X-OMAT AR Kodak film. Membranes were stripped by
5 min of exposure to 95°C distilled H20  containing 1% SDS before hy­
bridization with the next labeled probe. The probes used were: 1) CRP, 
pCRP5, kindly provided by H. R. Colten, Washington University, St. 
Louis, MO (17); and 2) SAA, pAlO (capable of detecting all SAA isotypes) 
courtesy of J. Sipe, Boston University, Boston, MA (18).
The intensities of 18S RNA bands on photographs of ethidium bromide- 
stained formaldehyde gels and of mRNA bands on autoradiographs were 
measured by using a UMAX scanner (Data System Inc., Hsinchu, Taiwan) 
with the software Intelligent Quantifier for Macintosh (Bio Image, Ann 
Arbor, MI). Densitometry of 18S rRNA bands was used to correct for 
minor technical variations and the autoradiograph band intensities were 
adjusted appropriately.
Statistical analysis
All results are shown as the mean ±  SEM. Comparison between groups 
was assessed by the unpaired nonparametric Mann Whitney U test. A p 
value of <0.05  was considered to be the lowest level of significance.
Results
Serum concentrations o f acute phase proteins
The CRP content in serum drawn from the patients was higher 
compared with the healthy control group, albeit the difference was 
not statistically significant (Table I). Serum from HIDS patients 
and FM F patients contained comparable quantities of SAA but the 
concentrations were (nonsignificantly) higher compared with the 
control group.
Cytokine production by PBMC
The concentrations of cytokines in CM, reflecting production by 
PBMC over 24 h of incubation, are indicated in Table II. CM 
derived from unstimulated PBMC from HIDS patients (HIDS- 
CM) contained significantly more IL - lß ,  IL-6, and TNF-a: than
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Table I. CRP and SAA content o f  serum trom HIDS and FMF 
patients and from healthy controls as measured by specific ELISA 
assays‘n
HIDS FMF Controls
CRP (mg/L) 4.1 ±  1.8 5.9 ±  2.5 0 .17  ±  0.03
SAA (mg/L) 6.9 ±  5.7 14.3 ±  7.9 0 .27  ±  0.05
■f Data are expressed as mean ± SEM in ng/ml.
did CM derived from PBMC of FMF patients (FMF-CM). FMF- 
CM, in turn, contained significantly more IL - lß  and IL-6, but not 
TN F-a, than did CM derived from PBMC of healthy controls (C- 
CM). In all three groups, cytokine production by PBMC stimulated 
with 100 ng/ml LPS was significantly increased compared with 
unstimulated PBMCs (Table I). Stimulated HIDS-CM contained 
threefold more IL -1 ß  and twofold more IL-6 than did stimulated 
FMF-CM. Unlike unstimulated PBMC, LPS-stimulated PBMC de­
rived from HIDS and FMF patients produced comparable amounts 
of TN F-a. LPS-stimulated FMF-CM contained more IL-6 than did 
C-CM, while IL-1 and T N F -a  production did not differ between 
these two groups.
Acute-phase response to CM
Unstimulated PBMC. Incubation of Hep3B cells for 24 h with 
unstimulated HIDS-CM resulted in fivefold greater accumulation 
of CRP in culture medium, reflecting greater production, than was 
observed with unstimulated FMF-CM ( p  <  0.001) or C-CM (/; <
0.005) (Fig. 1). Unstimulated HIDS-CM also caused significantly 
greater increases in levels of mRNA in Hep3B cells for CRP (sev­
enfold) and SAA (50-fold) than did unstimulated FMF-CM (Fig. 2, 
A and B). Unstimulated HIDS-CM induced about 2.6-fold higher 
CRP mRNA and fivefold higher mRNA levels for SAA than did 
C-CM but neither of these differences could be shown to achieve 
statistical significance.
LPS-stim ulated P B M C . For all three groups, stimulation with LPS 
led to production of CM capable of greater acute phase protein- 
inducing ability than was seen with unstimulated PBMC. Hep3B 
cells incubated with stimulated HIDS-CM secreted fivefold more 
CRP than did cells incubated with stimulated FMF-CM or C-CM 
(Fig. 3), and 2.4-fold more than cells incubated with unstimulated 
HIDS-CM {p  =  0.009). Following incubation of Hep 3B cells 
with LPS-stimulated HIDS-CM, CPR and SAA mRNA levels 
were significantly greater than was observed following incubation 
with FMF-CM or C-CM (Fig. 2, C and D). Serum SAA and CRP 
concentrations (determined during disease inactivity) did not cor­
relate with acute phase protein-inducing activity of both the stim­
ulated and unstimulated samples we tested.
Discussion
The major purpose of the current investigation was to determine 
the extent to which clinically observed differences in the magni­
tude of the acute phase response in HIDS and FMF patients, as 
measured by serum levels of acute phase proteins, could be attrib­
uted to differences in release of inflammatory cytokines by PBMC 
from these patients (Refs. 6 - 8 ;  and J. P. H. Drenth, personal ob­
servations). We found that unstimulated PBMC from patients with 
inactive HIDS released significantly more IL - lß ,  IL-6, and T N F-a  
than did PBMC from patients with FMF, and that CM from these 
cells induced significantly greater CRP production and signifi­
cantly more mRNA for CRP and SAA in Hep3B cells than did CM 
from FMF patients. These results support the hypothesis that dif­
ferences in the magnitude of the acute phase response between 
HIDS and FM F patients reflect differences in cytokine production 
by their PBMC and indicate that these effects on acute phase pro­
tein production are exerted at the pretranslational level. We studied 
PBMC rather than monocytes because isolation of monocytes in­
volves an adherence step that may itself activate these cells, which 
we wanted to avoid. To the extent to which findings in PBMC 
reflect the behavior of monocytes and tissue macrophages, our 
findings raise the possibility that macrophages may also produce 
large amounts of these inflammatory cytokines in patients with 
HIDS. The results from our study cannot be explained by differ­
ences in monocyte content in the PBMC since this was similar for 
all studied groups.
Serum SAA and CRP concentrations (determined during disease 
inactivity) were relatively low in both patient groups, although 
greater than those seen in controls, and did not correlate with acute 
phase protein-inducing activity of the samples we tested. This 
came as no surprise, since in vivo and in vitro circumstances are 
quite different. Our in vitro assay is relatively insensitive, based on 
protracted exposure of Hepatoma cells to an unchanging test sam­
ple, while in vivo acute phase protein levels reflect effects of con­
tinuous flow of plasma on in situ hepatocytes and of clearance of 
acute phase proteins from plasma.
In addition, our findings also indicate that PBMC are already 
markedly activated in vivo in patients with inactive HIDS. In con­
trast, unstimulated PBMC from patients with inactive FMF pro­
duced substantially less IL - lß  and IL-6, and their T N F -a  produc­
tion was indistinguishable from that seen in PBMC from healthy 
controls. Overproduction of cytokines by unstimulated PBMC 
from HIDS patients could be due either to faulty regulation of 
autonomous cytokine production or to the effects of an exogenous 
stimulatory factor. Recent findings favor the latter explanation; 
IgD isolated from HIDS patients has been found to stimulate nor­
mal human PBMC to produce large quantities of IL - lß ,  IL-6, 
TN F-a, and leukocyte inhibitory factor. (19). It is reasonable to 
conclude, in light of our current findings, that the high concentra­
tions of IgD seen in these patients serve as a continuous stimulus 
to inflammatory cytokine production, even during clinically inac­
tive periods. This conclusion is consistent with our previous ob­
servation that increased fucosylation of AGP, a phenomenon 
shown to be due to the effects of cytokines (20), is found in HIDS 
patients during asymptomatic intervals. The finding that CM de­
rived from unstimulated PBMC from HIDS patients in the inter- 
critical phase is able to induce an acute phase response in Hep3B 
cells, a relatively insensitive bioassay (21), supports this conclu­
sion, as does the observation that serum AGP concentrations are 
persistently elevated between attacks and increase slightly during 
febrile attacks of HIDS (20).
There has been similar interest in the effect of CM derived from 
circulating cells on the synthesis of acute phase proteins in other 
inflammatory disorders. Patients with active Crohn’s disease gen­
erally have higher circulating CRP concentrations compared with 
those with ulcerative colitis (22). IL - lß  and T N F -a  production by 
unstimulated peripheral monocytes was not different in cells from 
patients with Crohn’s disease than in those with ulcerative colitis, 
but LPS-stimulated cytokine production was significantly higher in 
monocytes from Crohn’s disease patients (22) and this difference 
was even greater during active disease. CM from both unstimu- 
lated and stimulated monocytes from patients with active C rohn’s 
disease induced greater release of CRP from PLC/PRF/5 human 
hepatoma cells than did CM from patients with active ulcerative 
colitis (23). Similarly, CM from unstimulated and LPS-stimulated
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i .ble II. IL-lß, IL-6, and TNF-a content o f CM from PBMC o f HIDS and FMF patients from healthy controls as measured by specific ELISA
¿¿says'1
Unstimulated LPS-Stimulated
HIDS FMF Controls HIDS FMF Controls
IL-1 ß 3.2 ±  1 .16 0 .64  ±  0 .4 C 0 .048  ±  0.4 63 ±  7.2h 19.8 ±  3.3 22 ±  6.9
IL-6 11.7 ±  4.6b 5.1 ±  2 .8 C 0.068  ±  0 .017 150 ±  2 3 .7 1* 73 ±  4 .1 c 15.3 ±  8
TN F -a 1.5 ±  0.7Sh 0 .072  ±  0 .04 0 .065  ±  0 .012 7.4 ±  2.4 5.5 ±  2.9 1.4 ±  0.8
'C M  was prepared from unstimulated PBMC or from PBMC stimulated with 100 ng/ml LPS. Data are expressed as mean ± SEM in ng/ml. 
h Indicates difference (p <  0.05) compared to FMF. 
c Indicates difference (p <  0.05) compared to controls.
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FIGURE 3. Effect of CM from LPS-stimulated PBMC of HIDS (■), 
FMF (□), and  healthy controls (HI) on production of CRP from Hep3B 
cells. Hep3B cells w ere  incubated  with 10% CM ob ta ined  from PBMC 
stimulated with 100 ng/ml E. coli LPS. After 24 h, supernatan ts  w ere  
harvested and CRP concentra tions  determ ined. Results are expressed 
as m ean ±  SEM. Stimulated HIDS-CM caused  significantly m ore CRP 
production  than did FMF-CM and C-CM (**, p <  0.01).
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FIGURE 2. Effect of CM from unstimulated PBMC {upper panel) and 
L S-stimulated PBMC (lower panel) of patients with HIDS (■), FMF 
1 , and healthy controls (ID) on levels of mRNA in Hep3B cells for 
C KP (A (unstimulated) and  C (stimulated)) and  SAA (B (unstimulated) 
ai: I D (stimulated)). Results are represented as fold increase over 
n KNA levels in unstim ulated  Hep3B cells. *, p  <  0.05 for HIDS pa­
tients co m pared  with FMF patients.
PBMC from patients with rheumatoid arthritis significantly in­
creased production of a,-antichymotrypsin and a,-proteinase in­
hibitor by HepG2 cells over levels achieved by CM from PBMC of 
patients with active systemic lupus erythematosus (24).
The differences we observed in the profile of cytokines produced 
by unstimulated PBMC from patients with inactive HIDS and 
FMF indicate both qualitative and quantitative differences in cy­
tokine production in patients with these two periodic inflammatory 
disorders during intercritical periods. Unstimulated PBMC from
FMF patients produced significantly more IL-6 and IL - lß ,  but not 
TN F-a, than did PBMC from normal controls, while PBMC from 
HIDS patients produced significantly more of all three cytokines 
than did FMF PBMC. Taken together with the observation that 
supernatants from both unstimulated and LPS-stimulated PBMC 
from HIDS and FMF patients differed in their capacity to elicit 
CRP production and acute phase protein mRNA changes in Hep3B 
cells, these findings suggest differences in the pathogenesis of 
these two intermittent febrile disorders.
Finally, the observation that HIDS PBMC, although already ac­
tivated, were able to respond to LPS stimulation with further in­
crease in cytokine production and increased acute phase protein- 
inducing capability is consistent with the hypothesis that acute 
febrile attacks are precipitated by unknown stimuli capable of fur­
ther increasing cytokine production. There is evidence that the 
ability to produce cytokines in HIDS patients increases during fe­
brile attacks. In these patients, LPS-stimulated ex vivo production 
of T N F -a  and IL - lß ,  as measured in a whole blood culture system, 
was found to be significantly greater during acute attacks than 
following defervescence (6). In contrast, LPS-stimulated T N F -a  
and IL - lß  production in supernatants of PBMC from FM F patients 
was markedly decreased during febrile attacks but normalized dur­
ing recovery (25-27). This apparent differential regulation of cy­
tokines during attacks in these two syndromes might further ex­
plain the difference in the magnitude of the acute phase response 
observed in vivo.
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